The development of PET imaging probes that are capable of targeting CD206 have the potential to advance the understanding of the biology of cancer as well as contribute to the discovery of innovative vehicles for the delivery of imaging or therapeutic agents to the tumor microenvironment. Here, MRC1 is linked to cancer.